JP2020521759A5

JP2020521759A5 -

Download PDF

Info

Publication number: JP2020521759A5
Authority: JP; Japan
Prior art keywords: seq; antibody; ligand; ecd; tim
Prior art date: 2018-05-25
Legal status : Pending

Application number

JP2019565233A

Other languages

English (en)

Japanese (ja)

Other versions

JP2020521759A (ja

Filing date

2018-05-25

Publication date

2021-07-26

2018-05-25 Application filed filed Critical

2018-05-25 Priority claimed from PCT/US2018/034755 external-priority patent/WO2018218215A1/en

2020-07-27 Publication of JP2020521759A publication Critical patent/JP2020521759A/ja

2021-07-26 Publication of JP2020521759A5 publication Critical patent/JP2020521759A5/ja

Status Pending legal-status Critical Current

Links

239000003446 ligand Substances 0.000 claims description 378
108090000765 processed proteins & peptides Proteins 0.000 claims description 324
230000027455 binding Effects 0.000 claims description 310
102000004196 processed proteins & peptides Human genes 0.000 claims description 279
229920001184 polypeptide Polymers 0.000 claims description 271
230000002519 immonomodulatory effect Effects 0.000 claims description 225
239000012634 fragment Substances 0.000 claims description 224
230000008685 targeting Effects 0.000 claims description 198
206010028980 Neoplasm Diseases 0.000 claims description 186
210000001744 T-lymphocyte Anatomy 0.000 claims description 179
101100519207 Mus musculus Pdcd1 gene Proteins 0.000 claims description 177
102000005962 receptors Human genes 0.000 claims description 80
108020003175 receptors Proteins 0.000 claims description 80
201000011510 cancer Diseases 0.000 claims description 54
239000000427 antigen Substances 0.000 claims description 47
108091007433 antigens Proteins 0.000 claims description 47
102000036639 antigens Human genes 0.000 claims description 47
108060003951 Immunoglobulin Proteins 0.000 claims description 31
102000018358 immunoglobulin Human genes 0.000 claims description 31
239000003112 inhibitor Substances 0.000 claims description 18
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 14
102100029822 B- and T-lymphocyte attenuator Human genes 0.000 claims description 12
102000004127 Cytokines Human genes 0.000 claims description 12
108090000695 Cytokines Proteins 0.000 claims description 12
102000009465 Growth Factor Receptors Human genes 0.000 claims description 11
108010009202 Growth Factor Receptors Proteins 0.000 claims description 11
108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 11
102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 11
230000002401 inhibitory effect Effects 0.000 claims description 11
201000010099 disease Diseases 0.000 claims description 10
102000003675 cytokine receptors Human genes 0.000 claims description 9
108010057085 cytokine receptors Proteins 0.000 claims description 9
210000003719 b-lymphocyte Anatomy 0.000 claims description 8
239000003102 growth factor Substances 0.000 claims description 8
230000001613 neoplastic effect Effects 0.000 claims description 3
101000712669 Homo sapiens TGF-beta receptor type-2 Proteins 0.000 claims description 2
102100033455 TGF-beta receptor type-2 Human genes 0.000 claims description 2
239000002955 immunomodulating agent Substances 0.000 claims description 2
101000864344 Homo sapiens B- and T-lymphocyte attenuator Proteins 0.000 claims 3
230000000973 chemotherapeutic effect Effects 0.000 claims 1
108020001507 fusion proteins Proteins 0.000 description 132
102000037865 fusion proteins Human genes 0.000 description 131
108090000623 proteins and genes Proteins 0.000 description 126
235000018102 proteins Nutrition 0.000 description 121
102000004169 proteins and genes Human genes 0.000 description 121
229960003852 atezolizumab Drugs 0.000 description 100
102100024533 Carcinoembryonic antigen-related cell adhesion molecule 1 Human genes 0.000 description 79
102100024216 Programmed cell death 1 ligand 1 Human genes 0.000 description 69
108010074708 B7-H1 Antigen Proteins 0.000 description 67
101710190843 Carcinoembryonic antigen-related cell adhesion molecule 1 Proteins 0.000 description 67
101001068133 Homo sapiens Hepatitis A virus cellular receptor 2 Proteins 0.000 description 63
102100034458 Hepatitis A virus cellular receptor 2 Human genes 0.000 description 59
101000666896 Homo sapiens V-type immunoglobulin domain-containing suppressor of T-cell activation Proteins 0.000 description 56
102100038282 V-type immunoglobulin domain-containing suppressor of T-cell activation Human genes 0.000 description 54
-1 41BB Proteins 0.000 description 51
108010021064 CTLA-4 Antigen Proteins 0.000 description 45
102000004887 Transforming Growth Factor beta Human genes 0.000 description 43
108090001012 Transforming Growth Factor beta Proteins 0.000 description 43
230000000875 corresponding effect Effects 0.000 description 42
102000008203 CTLA-4 Antigen Human genes 0.000 description 41
210000004027 cell Anatomy 0.000 description 41
102100038077 CD226 antigen Human genes 0.000 description 40
101000884298 Homo sapiens CD226 antigen Proteins 0.000 description 40
101001137987 Homo sapiens Lymphocyte activation gene 3 protein Proteins 0.000 description 40
108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 39
102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 39
108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 39
101000743493 Homo sapiens V-set and immunoglobulin domain-containing protein 8 Proteins 0.000 description 36
102100038355 V-set and immunoglobulin domain-containing protein 8 Human genes 0.000 description 36
101710149863 C-C chemokine receptor type 4 Proteins 0.000 description 33
230000003993 interaction Effects 0.000 description 33
230000014509 gene expression Effects 0.000 description 32
102100032976 CCR4-NOT transcription complex subunit 6 Human genes 0.000 description 31
210000004881 tumor cell Anatomy 0.000 description 31
102000050627 Glucocorticoid-Induced TNFR-Related Human genes 0.000 description 30
101710187882 Tumor necrosis factor receptor superfamily member 18 Proteins 0.000 description 30
102000000529 Costimulatory and Inhibitory T-Cell Receptors Human genes 0.000 description 29
108010041504 Costimulatory and Inhibitory T-Cell Receptors Proteins 0.000 description 29
102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 description 26
102100032912 CD44 antigen Human genes 0.000 description 25
101000868273 Homo sapiens CD44 antigen Proteins 0.000 description 25
102100020862 Lymphocyte activation gene 3 protein Human genes 0.000 description 25
230000006870 function Effects 0.000 description 25
ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 25
101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 description 24
102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 description 24
102100034922 T-cell surface glycoprotein CD8 alpha chain Human genes 0.000 description 23
230000006058 immune tolerance Effects 0.000 description 23
101000889276 Homo sapiens Cytotoxic T-lymphocyte protein 4 Proteins 0.000 description 22
102000014128 RANK Ligand Human genes 0.000 description 22
108010025832 RANK Ligand Proteins 0.000 description 22
230000004913 activation Effects 0.000 description 22
230000007246 mechanism Effects 0.000 description 21
238000011282 treatment Methods 0.000 description 21
238000000034 method Methods 0.000 description 20
102100029740 Poliovirus receptor Human genes 0.000 description 19
108091008605 VEGF receptors Proteins 0.000 description 19
102000009484 Vascular Endothelial Growth Factor Receptors Human genes 0.000 description 19
229960005386 ipilimumab Drugs 0.000 description 19
210000003289 regulatory T cell Anatomy 0.000 description 19
229940124676 vascular endothelial growth factor receptor Drugs 0.000 description 19
102100037792 Interleukin-6 receptor subunit alpha Human genes 0.000 description 18
230000001506 immunosuppresive effect Effects 0.000 description 18
230000004927 fusion Effects 0.000 description 17
229960003301 nivolumab Drugs 0.000 description 17
108010048507 poliovirus receptor Proteins 0.000 description 17
229960000575 trastuzumab Drugs 0.000 description 17
102100027581 Forkhead box protein P3 Human genes 0.000 description 16
101000861452 Homo sapiens Forkhead box protein P3 Proteins 0.000 description 16
230000006044 T cell activation Effects 0.000 description 16
102100022153 Tumor necrosis factor receptor superfamily member 4 Human genes 0.000 description 16
101710165473 Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 description 16
210000002443 helper t lymphocyte Anatomy 0.000 description 16
239000000203 mixture Substances 0.000 description 16
206010003571 Astrocytoma Diseases 0.000 description 15
102000017578 LAG3 Human genes 0.000 description 15
210000002865 immune cell Anatomy 0.000 description 15
229960002621 pembrolizumab Drugs 0.000 description 15
230000011664 signaling Effects 0.000 description 15
210000003171 tumor-infiltrating lymphocyte Anatomy 0.000 description 15
102100024263 CD160 antigen Human genes 0.000 description 14
229940045513 CTLA4 antagonist Drugs 0.000 description 14
101000761938 Homo sapiens CD160 antigen Proteins 0.000 description 14
108010043610 KIR Receptors Proteins 0.000 description 14
102000002698 KIR Receptors Human genes 0.000 description 14
241000699670 Mus sp. Species 0.000 description 14
229960000397 bevacizumab Drugs 0.000 description 14
229960005395 cetuximab Drugs 0.000 description 14
229960003989 tocilizumab Drugs 0.000 description 14
101000596234 Homo sapiens T-cell surface protein tactile Proteins 0.000 description 13
108010061593 Member 14 Tumor Necrosis Factor Receptors Proteins 0.000 description 13
108091008874 T cell receptors Proteins 0.000 description 13
102000016266 T-Cell Antigen Receptors Human genes 0.000 description 13
102100035268 T-cell surface protein tactile Human genes 0.000 description 13
102100028785 Tumor necrosis factor receptor superfamily member 14 Human genes 0.000 description 13
108010062802 CD66 antigens Proteins 0.000 description 12
101710100969 Receptor tyrosine-protein kinase erbB-3 Proteins 0.000 description 12
101710100963 Receptor tyrosine-protein kinase erbB-4 Proteins 0.000 description 12
230000002496 gastric effect Effects 0.000 description 12
208000032839 leukemia Diseases 0.000 description 12
208000003174 Brain Neoplasms Diseases 0.000 description 11
102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 description 11
108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 description 11
206010025323 Lymphomas Diseases 0.000 description 11
102100035488 Nectin-2 Human genes 0.000 description 11
206010039491 Sarcoma Diseases 0.000 description 11
239000012636 effector Substances 0.000 description 11
230000035755 proliferation Effects 0.000 description 11
206010063836 Atrioventricular septal defect Diseases 0.000 description 10
102000001301 EGF receptor Human genes 0.000 description 10
101000599048 Homo sapiens Interleukin-6 receptor subunit alpha Proteins 0.000 description 10
102100020943 Leukocyte-associated immunoglobulin-like receptor 1 Human genes 0.000 description 10
102100036856 Tumor necrosis factor receptor superfamily member 9 Human genes 0.000 description 10
101710165434 Tumor necrosis factor receptor superfamily member 9 Proteins 0.000 description 10
230000003305 autocrine Effects 0.000 description 10
229950002916 avelumab Drugs 0.000 description 10
238000010586 diagram Methods 0.000 description 10
230000004069 differentiation Effects 0.000 description 10
230000000694 effects Effects 0.000 description 10
238000001211 electron capture detection Methods 0.000 description 10
108010025001 leukocyte-associated immunoglobulin-like receptor 1 Proteins 0.000 description 10
244000052769 pathogen Species 0.000 description 10
101710144268 B- and T-lymphocyte attenuator Proteins 0.000 description 9
102000004889 Interleukin-6 Human genes 0.000 description 9
108090001005 Interleukin-6 Proteins 0.000 description 9
210000000612 antigen-presenting cell Anatomy 0.000 description 9
230000034994 death Effects 0.000 description 9
230000008472 epithelial growth Effects 0.000 description 9
229940100601 interleukin-6 Drugs 0.000 description 9
230000037361 pathway Effects 0.000 description 9
230000004083 survival effect Effects 0.000 description 9
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 8
101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 description 8
101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 description 8
101000916644 Homo sapiens Macrophage colony-stimulating factor 1 receptor Proteins 0.000 description 8
241000725303 Human immunodeficiency virus Species 0.000 description 8
102000053646 Inducible T-Cell Co-Stimulator Human genes 0.000 description 8
108700013161 Inducible T-Cell Co-Stimulator Proteins 0.000 description 8
108010074328 Interferon-gamma Proteins 0.000 description 8
102100027268 Interferon-stimulated gene 20 kDa protein Human genes 0.000 description 8
102100028198 Macrophage colony-stimulating factor 1 receptor Human genes 0.000 description 8
108010057466 NF-kappa B Proteins 0.000 description 8
102000003945 NF-kappa B Human genes 0.000 description 8
229940126547 T-cell immunoglobulin mucin-3 Drugs 0.000 description 8
102000016715 Transforming Growth Factor beta Receptors Human genes 0.000 description 8
230000001154 acute effect Effects 0.000 description 8
208000015181 infectious disease Diseases 0.000 description 8
108040006858 interleukin-6 receptor activity proteins Proteins 0.000 description 8
230000001404 mediated effect Effects 0.000 description 8
239000000126 substance Substances 0.000 description 8
230000001629 suppression Effects 0.000 description 8
241001529453 unidentified herpesvirus Species 0.000 description 8
102100022464 5'-nucleotidase Human genes 0.000 description 7
206010006187 Breast cancer Diseases 0.000 description 7
208000026310 Breast neoplasm Diseases 0.000 description 7
102100035875 C-C chemokine receptor type 5 Human genes 0.000 description 7
101710149870 C-C chemokine receptor type 5 Proteins 0.000 description 7
102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 description 7
102100029722 Ectonucleoside triphosphate diphosphohydrolase 1 Human genes 0.000 description 7
206010018338 Glioma Diseases 0.000 description 7
241000282412 Homo Species 0.000 description 7
101000678236 Homo sapiens 5'-nucleotidase Proteins 0.000 description 7
101000922348 Homo sapiens C-X-C chemokine receptor type 4 Proteins 0.000 description 7
101001012447 Homo sapiens Ectonucleoside triphosphate diphosphohydrolase 1 Proteins 0.000 description 7
102000037982 Immune checkpoint proteins Human genes 0.000 description 7
108091008036 Immune checkpoint proteins Proteins 0.000 description 7
206010061598 Immunodeficiency Diseases 0.000 description 7
208000029462 Immunodeficiency disease Diseases 0.000 description 7
108050003558 Interleukin-17 Proteins 0.000 description 7
102000013691 Interleukin-17 Human genes 0.000 description 7
102100033178 Vascular endothelial growth factor receptor 1 Human genes 0.000 description 7
230000003213 activating effect Effects 0.000 description 7
230000003044 adaptive effect Effects 0.000 description 7
239000011324 bead Substances 0.000 description 7
238000006471 dimerization reaction Methods 0.000 description 7
210000003162 effector t lymphocyte Anatomy 0.000 description 7
230000007813 immunodeficiency Effects 0.000 description 7
238000009169 immunotherapy Methods 0.000 description 7
238000000338 in vitro Methods 0.000 description 7
238000001727 in vivo Methods 0.000 description 7
201000001441 melanoma Diseases 0.000 description 7
210000000822 natural killer cell Anatomy 0.000 description 7
230000003076 paracrine Effects 0.000 description 7
210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 7
230000035935 pregnancy Effects 0.000 description 7
210000001519 tissue Anatomy 0.000 description 7
230000001131 transforming effect Effects 0.000 description 7
101100067974 Arabidopsis thaliana POP2 gene Proteins 0.000 description 6
108020004414 DNA Proteins 0.000 description 6
238000002965 ELISA Methods 0.000 description 6
101150029707 ERBB2 gene Proteins 0.000 description 6
101150039808 Egfr gene Proteins 0.000 description 6
102100031940 Epithelial cell adhesion molecule Human genes 0.000 description 6
102100031351 Galectin-9 Human genes 0.000 description 6
101710121810 Galectin-9 Proteins 0.000 description 6
101100118549 Homo sapiens EGFR gene Proteins 0.000 description 6
101100232351 Homo sapiens IL12RB1 gene Proteins 0.000 description 6
101001019598 Homo sapiens Interleukin-17 receptor A Proteins 0.000 description 6
101000853012 Homo sapiens Interleukin-23 receptor Proteins 0.000 description 6
102100037850 Interferon gamma Human genes 0.000 description 6
102100020790 Interleukin-12 receptor subunit beta-1 Human genes 0.000 description 6
102100035018 Interleukin-17 receptor A Human genes 0.000 description 6
102100036672 Interleukin-23 receptor Human genes 0.000 description 6
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 6
102100029986 Receptor tyrosine-protein kinase erbB-3 Human genes 0.000 description 6
102100029981 Receptor tyrosine-protein kinase erbB-4 Human genes 0.000 description 6
101100123851 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) HER1 gene Proteins 0.000 description 6
108091005735 TGF-beta receptors Proteins 0.000 description 6
108010065158 Tumor Necrosis Factor Ligand Superfamily Member 14 Proteins 0.000 description 6
102100024586 Tumor necrosis factor ligand superfamily member 14 Human genes 0.000 description 6
239000000556 agonist Substances 0.000 description 6
102000012740 beta Adrenergic Receptors Human genes 0.000 description 6
108010079452 beta Adrenergic Receptors Proteins 0.000 description 6
231100000433 cytotoxic Toxicity 0.000 description 6
230000001472 cytotoxic effect Effects 0.000 description 6
230000001939 inductive effect Effects 0.000 description 6
201000007270 liver cancer Diseases 0.000 description 6
230000003211 malignant effect Effects 0.000 description 6
210000004379 membrane Anatomy 0.000 description 6
239000012528 membrane Substances 0.000 description 6
101710135378 pH 6 antigen Proteins 0.000 description 6
230000004044 response Effects 0.000 description 6
102100038078 CD276 antigen Human genes 0.000 description 5
101710185679 CD276 antigen Proteins 0.000 description 5
108010022366 Carcinoembryonic Antigen Proteins 0.000 description 5
102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 description 5
201000009030 Carcinoma Diseases 0.000 description 5
208000032612 Glial tumor Diseases 0.000 description 5
206010061309 Neoplasm progression Diseases 0.000 description 5
208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 5
206010061902 Pancreatic neoplasm Diseases 0.000 description 5
230000006052 T cell proliferation Effects 0.000 description 5
102000040945 Transcription factor Human genes 0.000 description 5
108091023040 Transcription factor Proteins 0.000 description 5
108060008682 Tumor Necrosis Factor Proteins 0.000 description 5
108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 5
102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 5
102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 description 5
230000002159 abnormal effect Effects 0.000 description 5
125000000539 amino acid group Chemical group 0.000 description 5
230000005809 anti-tumor immunity Effects 0.000 description 5
230000024245 cell differentiation Effects 0.000 description 5
239000013592 cell lysate Substances 0.000 description 5
230000001684 chronic effect Effects 0.000 description 5
108091008034 costimulatory receptors Proteins 0.000 description 5
210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 5
238000005516 engineering process Methods 0.000 description 5
238000005734 heterodimerization reaction Methods 0.000 description 5
238000001114 immunoprecipitation Methods 0.000 description 5
230000006698 induction Effects 0.000 description 5
230000009545 invasion Effects 0.000 description 5
210000004698 lymphocyte Anatomy 0.000 description 5
208000015486 malignant pancreatic neoplasm Diseases 0.000 description 5
201000002528 pancreatic cancer Diseases 0.000 description 5
208000008443 pancreatic carcinoma Diseases 0.000 description 5
229960002087 pertuzumab Drugs 0.000 description 5
230000002829 reductive effect Effects 0.000 description 5
230000004614 tumor growth Effects 0.000 description 5
102000003298 tumor necrosis factor receptor Human genes 0.000 description 5
230000005751 tumor progression Effects 0.000 description 5
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 5
206010005003 Bladder cancer Diseases 0.000 description 4
102100027207 CD27 antigen Human genes 0.000 description 4
101150013553 CD40 gene Proteins 0.000 description 4
108060006698 EGF receptor Proteins 0.000 description 4
101000914511 Homo sapiens CD27 antigen Proteins 0.000 description 4
101000920667 Homo sapiens Epithelial cell adhesion molecule Proteins 0.000 description 4
101001055145 Homo sapiens Interleukin-2 receptor subunit beta Proteins 0.000 description 4
101000868279 Homo sapiens Leukocyte surface antigen CD47 Proteins 0.000 description 4
206010062016 Immunosuppression Diseases 0.000 description 4
102100021317 Inducible T-cell costimulator Human genes 0.000 description 4
101710205775 Inducible T-cell costimulator Proteins 0.000 description 4
102100026879 Interleukin-2 receptor subunit beta Human genes 0.000 description 4
102000013264 Interleukin-23 Human genes 0.000 description 4
108010065637 Interleukin-23 Proteins 0.000 description 4
102100032913 Leukocyte surface antigen CD47 Human genes 0.000 description 4
206010058467 Lung neoplasm malignant Diseases 0.000 description 4
102100022430 Melanocyte protein PMEL Human genes 0.000 description 4
241001465754 Metazoa Species 0.000 description 4
208000003445 Mouth Neoplasms Diseases 0.000 description 4
208000034578 Multiple myelomas Diseases 0.000 description 4
102000010648 Natural Killer Cell Receptors Human genes 0.000 description 4
108010077854 Natural Killer Cell Receptors Proteins 0.000 description 4
206010061535 Ovarian neoplasm Diseases 0.000 description 4
206010035226 Plasma cell myeloma Diseases 0.000 description 4
102100040678 Programmed cell death protein 1 Human genes 0.000 description 4
208000015634 Rectal Neoplasms Diseases 0.000 description 4
230000020385 T cell costimulation Effects 0.000 description 4
102000006747 Transforming Growth Factor alpha Human genes 0.000 description 4
101800004564 Transforming growth factor alpha Proteins 0.000 description 4
208000003721 Triple Negative Breast Neoplasms Diseases 0.000 description 4
102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 description 4
208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 4
108010053096 Vascular Endothelial Growth Factor Receptor-1 Proteins 0.000 description 4
241000700605 Viruses Species 0.000 description 4
150000001413 amino acids Chemical group 0.000 description 4
238000004458 analytical method Methods 0.000 description 4
239000005557 antagonist Substances 0.000 description 4
230000000259 anti-tumor effect Effects 0.000 description 4
230000010056 antibody-dependent cellular cytotoxicity Effects 0.000 description 4
230000015572 biosynthetic process Effects 0.000 description 4
230000000903 blocking effect Effects 0.000 description 4
210000002798 bone marrow cell Anatomy 0.000 description 4
230000003915 cell function Effects 0.000 description 4
230000016396 cytokine production Effects 0.000 description 4
210000004443 dendritic cell Anatomy 0.000 description 4
208000035475 disorder Diseases 0.000 description 4
230000004064 dysfunction Effects 0.000 description 4
230000001605 fetal effect Effects 0.000 description 4
201000010536 head and neck cancer Diseases 0.000 description 4
208000014829 head and neck neoplasm Diseases 0.000 description 4
102000027596 immune receptors Human genes 0.000 description 4
108091008915 immune receptors Proteins 0.000 description 4
210000000987 immune system Anatomy 0.000 description 4
229940121354 immunomodulator Drugs 0.000 description 4
239000012133 immunoprecipitate Substances 0.000 description 4
230000005764 inhibitory process Effects 0.000 description 4
238000001361 intraarterial administration Methods 0.000 description 4
208000012987 lip and oral cavity carcinoma Diseases 0.000 description 4
208000014018 liver neoplasm Diseases 0.000 description 4
201000005202 lung cancer Diseases 0.000 description 4
208000020816 lung neoplasm Diseases 0.000 description 4
230000001394 metastastic effect Effects 0.000 description 4
206010061289 metastatic neoplasm Diseases 0.000 description 4
230000035772 mutation Effects 0.000 description 4
230000014306 paracrine signaling Effects 0.000 description 4
239000013612 plasmid Substances 0.000 description 4
238000010837 poor prognosis Methods 0.000 description 4
230000002062 proliferating effect Effects 0.000 description 4
206010038038 rectal cancer Diseases 0.000 description 4
201000001275 rectum cancer Diseases 0.000 description 4
230000019491 signal transduction Effects 0.000 description 4
201000000849 skin cancer Diseases 0.000 description 4
241000894007 species Species 0.000 description 4
210000002784 stomach Anatomy 0.000 description 4
208000022679 triple-negative breast carcinoma Diseases 0.000 description 4
201000005112 urinary bladder cancer Diseases 0.000 description 4
208000030507 AIDS Diseases 0.000 description 3
208000003200 Adenoma Diseases 0.000 description 3
206010001233 Adenoma benign Diseases 0.000 description 3
208000006468 Adrenal Cortex Neoplasms Diseases 0.000 description 3
229920000936 Agarose Polymers 0.000 description 3
239000004475 Arginine Substances 0.000 description 3
108010029697 CD40 Ligand Proteins 0.000 description 3
102100032937 CD40 ligand Human genes 0.000 description 3
102100025570 Cancer/testis antigen 1 Human genes 0.000 description 3
206010009944 Colon cancer Diseases 0.000 description 3
208000035473 Communicable disease Diseases 0.000 description 3
208000000461 Esophageal Neoplasms Diseases 0.000 description 3
108091008794 FGF receptors Proteins 0.000 description 3
102000044168 Fibroblast Growth Factor Receptor Human genes 0.000 description 3
108010001517 Galectin 3 Proteins 0.000 description 3
102100039558 Galectin-3 Human genes 0.000 description 3
101000856237 Homo sapiens Cancer/testis antigen 1 Proteins 0.000 description 3
101001133056 Homo sapiens Mucin-1 Proteins 0.000 description 3
101000851018 Homo sapiens Vascular endothelial growth factor receptor 1 Proteins 0.000 description 3
101000851007 Homo sapiens Vascular endothelial growth factor receptor 2 Proteins 0.000 description 3
241000701806 Human papillomavirus Species 0.000 description 3
102000014150 Interferons Human genes 0.000 description 3
108010050904 Interferons Proteins 0.000 description 3
208000008839 Kidney Neoplasms Diseases 0.000 description 3
206010023825 Laryngeal cancer Diseases 0.000 description 3
206010062038 Lip neoplasm Diseases 0.000 description 3
102100028389 Melanoma antigen recognized by T-cells 1 Human genes 0.000 description 3
102100034256 Mucin-1 Human genes 0.000 description 3
241000699666 Mus <mouse, genus> Species 0.000 description 3
208000001894 Nasopharyngeal Neoplasms Diseases 0.000 description 3
206010061306 Nasopharyngeal cancer Diseases 0.000 description 3
206010030155 Oesophageal carcinoma Diseases 0.000 description 3
206010033128 Ovarian cancer Diseases 0.000 description 3
108091008606 PDGF receptors Proteins 0.000 description 3
102000011653 Platelet-Derived Growth Factor Receptors Human genes 0.000 description 3
102100024213 Programmed cell death 1 ligand 2 Human genes 0.000 description 3
206010060862 Prostate cancer Diseases 0.000 description 3
208000000236 Prostatic Neoplasms Diseases 0.000 description 3
241000700159 Rattus Species 0.000 description 3
108020004511 Recombinant DNA Proteins 0.000 description 3
206010038389 Renal cancer Diseases 0.000 description 3
208000000453 Skin Neoplasms Diseases 0.000 description 3
102000004584 Somatomedin Receptors Human genes 0.000 description 3
108010017622 Somatomedin Receptors Proteins 0.000 description 3
238000000692 Student's t-test Methods 0.000 description 3
208000024313 Testicular Neoplasms Diseases 0.000 description 3
208000024770 Thyroid neoplasm Diseases 0.000 description 3
102100023935 Transmembrane glycoprotein NMB Human genes 0.000 description 3
208000009956 adenocarcinoma Diseases 0.000 description 3
201000002454 adrenal cortex cancer Diseases 0.000 description 3
230000003302 anti-idiotype Effects 0.000 description 3
230000005975 antitumor immune response Effects 0.000 description 3
230000006907 apoptotic process Effects 0.000 description 3
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
230000008267 autocrine signaling Effects 0.000 description 3
230000004071 biological effect Effects 0.000 description 3
210000004899 c-terminal region Anatomy 0.000 description 3
210000000170 cell membrane Anatomy 0.000 description 3
208000030239 cerebral astrocytoma Diseases 0.000 description 3
239000002299 complementary DNA Substances 0.000 description 3
210000005220 cytoplasmic tail Anatomy 0.000 description 3
238000011161 development Methods 0.000 description 3
230000018109 developmental process Effects 0.000 description 3
230000003828 downregulation Effects 0.000 description 3
229950009791 durvalumab Drugs 0.000 description 3
201000004101 esophageal cancer Diseases 0.000 description 3
230000012010 growth Effects 0.000 description 3
238000011577 humanized mouse model Methods 0.000 description 3
239000012642 immune effector Substances 0.000 description 3
230000028993 immune response Effects 0.000 description 3
238000003119 immunoblot Methods 0.000 description 3
238000011081 inoculation Methods 0.000 description 3
102000028416 insulin-like growth factor binding Human genes 0.000 description 3
108091022911 insulin-like growth factor binding Proteins 0.000 description 3
229940079322 interferon Drugs 0.000 description 3
230000031261 interleukin-10 production Effects 0.000 description 3
108040006849 interleukin-2 receptor activity proteins Proteins 0.000 description 3
230000003834 intracellular effect Effects 0.000 description 3
201000010982 kidney cancer Diseases 0.000 description 3
210000000244 kidney pelvis Anatomy 0.000 description 3
206010023841 laryngeal neoplasm Diseases 0.000 description 3
201000006721 lip cancer Diseases 0.000 description 3
238000012423 maintenance Methods 0.000 description 3
230000014759 maintenance of location Effects 0.000 description 3
208000030883 malignant astrocytoma Diseases 0.000 description 3
208000025854 malignant tumor of adrenal cortex Diseases 0.000 description 3
229960000513 necitumumab Drugs 0.000 description 3
229960001972 panitumumab Drugs 0.000 description 3
238000007911 parenteral administration Methods 0.000 description 3
230000001717 pathogenic effect Effects 0.000 description 3
238000010647 peptide synthesis reaction Methods 0.000 description 3
230000026731 phosphorylation Effects 0.000 description 3
238000006366 phosphorylation reaction Methods 0.000 description 3
230000001737 promoting effect Effects 0.000 description 3
210000003370 receptor cell Anatomy 0.000 description 3
230000007115 recruitment Effects 0.000 description 3
230000001105 regulatory effect Effects 0.000 description 3
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
239000007790 solid phase Substances 0.000 description 3
230000000638 stimulation Effects 0.000 description 3
238000007920 subcutaneous administration Methods 0.000 description 3
239000006228 supernatant Substances 0.000 description 3
238000003786 synthesis reaction Methods 0.000 description 3
238000012353 t test Methods 0.000 description 3
201000003120 testicular cancer Diseases 0.000 description 3
238000002560 therapeutic procedure Methods 0.000 description 3
210000000115 thoracic cavity Anatomy 0.000 description 3
201000002510 thyroid cancer Diseases 0.000 description 3
238000002054 transplantation Methods 0.000 description 3
VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 3
210000000239 visual pathway Anatomy 0.000 description 3
230000004400 visual pathway Effects 0.000 description 3
QNRATNLHPGXHMA-XZHTYLCXSA-N (r)-(6-ethoxyquinolin-4-yl)-[(2s,4s,5r)-5-ethyl-1-azabicyclo[2.2.2]octan-2-yl]methanol;hydrochloride Chemical compound Cl.C([C@H]([C@H](C1)CC)C2)CN1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OCC)C=C21 QNRATNLHPGXHMA-XZHTYLCXSA-N 0.000 description 2
BJHCYTJNPVGSBZ-YXSASFKJSA-N 1-[4-[6-amino-5-[(Z)-methoxyiminomethyl]pyrimidin-4-yl]oxy-2-chlorophenyl]-3-ethylurea Chemical compound CCNC(=O)Nc1ccc(Oc2ncnc(N)c2\C=N/OC)cc1Cl BJHCYTJNPVGSBZ-YXSASFKJSA-N 0.000 description 2
102000002627 4-1BB Ligand Human genes 0.000 description 2
108010082808 4-1BB Ligand Proteins 0.000 description 2
102100030310 5,6-dihydroxyindole-2-carboxylic acid oxidase Human genes 0.000 description 2
101710163881 5,6-dihydroxyindole-2-carboxylic acid oxidase Proteins 0.000 description 2
102100037982 Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A Human genes 0.000 description 2
102100032187 Androgen receptor Human genes 0.000 description 2
108091008875 B cell receptors Proteins 0.000 description 2
101150018195 BAG6 gene Proteins 0.000 description 2
206010061692 Benign muscle neoplasm Diseases 0.000 description 2
206010004593 Bile duct cancer Diseases 0.000 description 2
206010006143 Brain stem glioma Diseases 0.000 description 2
102100037853 C-C chemokine receptor type 4 Human genes 0.000 description 2
102100028666 C-type lectin domain family 4 member G Human genes 0.000 description 2
101150004010 CXCR3 gene Proteins 0.000 description 2
241000283707 Capra Species 0.000 description 2
108010051152 Carboxylesterase Proteins 0.000 description 2
102000013392 Carboxylesterase Human genes 0.000 description 2
102100038916 Caspase-5 Human genes 0.000 description 2
101710090333 Caspase-5 Proteins 0.000 description 2
102100026548 Caspase-8 Human genes 0.000 description 2
108090000538 Caspase-8 Proteins 0.000 description 2
241000700198 Cavia Species 0.000 description 2
102000000844 Cell Surface Receptors Human genes 0.000 description 2
108010001857 Cell Surface Receptors Proteins 0.000 description 2
102100034929 Cell division cycle protein 27 homolog Human genes 0.000 description 2
102100025064 Cellular tumor antigen p53 Human genes 0.000 description 2
206010007953 Central nervous system lymphoma Diseases 0.000 description 2
241000282693 Cercopithecidae Species 0.000 description 2
206010008342 Cervix carcinoma Diseases 0.000 description 2
102000009410 Chemokine receptor Human genes 0.000 description 2
108050000299 Chemokine receptor Proteins 0.000 description 2
102100023509 Chloride channel protein 2 Human genes 0.000 description 2
241000699800 Cricetinae Species 0.000 description 2
102000013701 Cyclin-Dependent Kinase 4 Human genes 0.000 description 2
108010025464 Cyclin-Dependent Kinase 4 Proteins 0.000 description 2
108010043648 Discoidin Domain Receptors Proteins 0.000 description 2
102000002706 Discoidin Domain Receptors Human genes 0.000 description 2
102100031334 Elongation factor 2 Human genes 0.000 description 2
206010014733 Endometrial cancer Diseases 0.000 description 2
206010014759 Endometrial neoplasm Diseases 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
101800003838 Epidermal growth factor Proteins 0.000 description 2
108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 description 2
241000283086 Equidae Species 0.000 description 2
102100038595 Estrogen receptor Human genes 0.000 description 2
102100037362 Fibronectin Human genes 0.000 description 2
108010067306 Fibronectins Proteins 0.000 description 2
101710113436 GTPase KRas Proteins 0.000 description 2
102100039788 GTPase NRas Human genes 0.000 description 2
241000287828 Gallus gallus Species 0.000 description 2
102100041003 Glutamate carboxypeptidase 2 Human genes 0.000 description 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
108010074032 HLA-A2 Antigen Proteins 0.000 description 2
102000007346 Hepatitis A Virus Cellular Receptor 2 Human genes 0.000 description 2
208000005176 Hepatitis C Diseases 0.000 description 2
108010033040 Histones Proteins 0.000 description 2
208000017604 Hodgkin disease Diseases 0.000 description 2
208000021519 Hodgkin lymphoma Diseases 0.000 description 2
208000010747 Hodgkins lymphoma Diseases 0.000 description 2
101000766915 Homo sapiens C-type lectin domain family 4 member G Proteins 0.000 description 2
101100220044 Homo sapiens CD34 gene Proteins 0.000 description 2
101000946837 Homo sapiens Cell division cycle protein 27 homolog Proteins 0.000 description 2
101000906633 Homo sapiens Chloride channel protein 2 Proteins 0.000 description 2
101000744505 Homo sapiens GTPase NRas Proteins 0.000 description 2
101000892862 Homo sapiens Glutamate carboxypeptidase 2 Proteins 0.000 description 2
101000586618 Homo sapiens Poliovirus receptor Proteins 0.000 description 2
101000713602 Homo sapiens T-box transcription factor TBX21 Proteins 0.000 description 2
101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 description 2
101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 description 2
102000018071 Immunoglobulin Fc Fragments Human genes 0.000 description 2
108010091135 Immunoglobulin Fc Fragments Proteins 0.000 description 2
102000008070 Interferon-gamma Human genes 0.000 description 2
108010017515 Interleukin-12 Receptors Proteins 0.000 description 2
102000004560 Interleukin-12 Receptors Human genes 0.000 description 2
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
239000004472 Lysine Substances 0.000 description 2
108010010995 MART-1 Antigen Proteins 0.000 description 2
108091054438 MHC class II family Proteins 0.000 description 2
102000043131 MHC class II family Human genes 0.000 description 2
108700018351 Major Histocompatibility Complex Proteins 0.000 description 2
206010027476 Metastases Diseases 0.000 description 2
201000004458 Myoma Diseases 0.000 description 2
102000007607 Non-Receptor Type 11 Protein Tyrosine Phosphatase Human genes 0.000 description 2
108010032107 Non-Receptor Type 11 Protein Tyrosine Phosphatase Proteins 0.000 description 2
102000002001 Non-Receptor Type 6 Protein Tyrosine Phosphatase Human genes 0.000 description 2
108010015793 Non-Receptor Type 6 Protein Tyrosine Phosphatase Proteins 0.000 description 2
208000010505 Nose Neoplasms Diseases 0.000 description 2
241000283973 Oryctolagus cuniculus Species 0.000 description 2
239000002033 PVDF binder Substances 0.000 description 2
241001494479 Pecora Species 0.000 description 2
108010077519 Peptide Elongation Factor 2 Proteins 0.000 description 2
102100040283 Peptidyl-prolyl cis-trans isomerase B Human genes 0.000 description 2
108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 2
102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 2
108091000080 Phosphotransferase Proteins 0.000 description 2
208000007452 Plasmacytoma Diseases 0.000 description 2
208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 2
241000288906 Primates Species 0.000 description 2
102100033237 Pro-epidermal growth factor Human genes 0.000 description 2
108700030875 Programmed Cell Death 1 Ligand 2 Proteins 0.000 description 2
108010072866 Prostate-Specific Antigen Proteins 0.000 description 2
102100038358 Prostate-specific antigen Human genes 0.000 description 2
102100035703 Prostatic acid phosphatase Human genes 0.000 description 2
201000000582 Retinoblastoma Diseases 0.000 description 2
101710173693 Short transient receptor potential channel 1 Proteins 0.000 description 2
208000021712 Soft tissue sarcoma Diseases 0.000 description 2
208000000102 Squamous Cell Carcinoma of Head and Neck Diseases 0.000 description 2
230000005867 T cell response Effects 0.000 description 2
102100036840 T-box transcription factor TBX21 Human genes 0.000 description 2
102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 description 2
102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 description 2
108010017842 Telomerase Proteins 0.000 description 2
206010057644 Testis cancer Diseases 0.000 description 2
102000002689 Toll-like receptor Human genes 0.000 description 2
108020000411 Toll-like receptor Proteins 0.000 description 2
108010092867 Transforming Growth Factor beta Receptors Proteins 0.000 description 2
LVTKHGUGBGNBPL-UHFFFAOYSA-N Trp-P-1 Chemical compound N1C2=CC=CC=C2C2=C1C(C)=C(N)N=C2C LVTKHGUGBGNBPL-UHFFFAOYSA-N 0.000 description 2
102100039094 Tyrosinase Human genes 0.000 description 2
108060008724 Tyrosinase Proteins 0.000 description 2
208000006593 Urologic Neoplasms Diseases 0.000 description 2
208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 2
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
108010053099 Vascular Endothelial Growth Factor Receptor-2 Proteins 0.000 description 2
108010053100 Vascular Endothelial Growth Factor Receptor-3 Proteins 0.000 description 2
102100033179 Vascular endothelial growth factor receptor 3 Human genes 0.000 description 2
208000033559 Waldenström macroglobulinemia Diseases 0.000 description 2
108700025700 Wilms Tumor Genes Proteins 0.000 description 2
210000000577 adipose tissue Anatomy 0.000 description 2
229960002833 aflibercept Drugs 0.000 description 2
108010081667 aflibercept Proteins 0.000 description 2
235000001014 amino acid Nutrition 0.000 description 2
229940024606 amino acid Drugs 0.000 description 2
108010080146 androgen receptors Proteins 0.000 description 2
230000014102 antigen processing and presentation of exogenous peptide antigen via MHC class I Effects 0.000 description 2
235000003704 aspartic acid Nutrition 0.000 description 2
238000003556 assay Methods 0.000 description 2
230000008901 benefit Effects 0.000 description 2
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
210000000941 bile Anatomy 0.000 description 2
230000033228 biological regulation Effects 0.000 description 2
OWMVSZAMULFTJU-UHFFFAOYSA-N bis-tris Chemical compound OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 description 2
201000000053 blastoma Diseases 0.000 description 2
239000000872 buffer Substances 0.000 description 2
208000035269 cancer or benign tumor Diseases 0.000 description 2
230000001413 cellular effect Effects 0.000 description 2
230000007969 cellular immunity Effects 0.000 description 2
210000003169 central nervous system Anatomy 0.000 description 2
201000010881 cervical cancer Diseases 0.000 description 2
238000006243 chemical reaction Methods 0.000 description 2
239000003153 chemical reaction reagent Substances 0.000 description 2
239000003638 chemical reducing agent Substances 0.000 description 2
235000013330 chicken meat Nutrition 0.000 description 2
208000011654 childhood malignant neoplasm Diseases 0.000 description 2
208000029742 colonic neoplasm Diseases 0.000 description 2
108010048032 cyclophilin B Proteins 0.000 description 2
230000001086 cytosolic effect Effects 0.000 description 2
230000003013 cytotoxicity Effects 0.000 description 2
231100000135 cytotoxicity Toxicity 0.000 description 2
230000007423 decrease Effects 0.000 description 2
230000002950 deficient Effects 0.000 description 2
238000012217 deletion Methods 0.000 description 2
230000037430 deletion Effects 0.000 description 2
238000001514 detection method Methods 0.000 description 2
239000003937 drug carrier Substances 0.000 description 2
201000008184 embryoma Diseases 0.000 description 2
210000002308 embryonic cell Anatomy 0.000 description 2
229940116977 epidermal growth factor Drugs 0.000 description 2
210000000981 epithelium Anatomy 0.000 description 2
108010038795 estrogen receptors Proteins 0.000 description 2
208000024519 eye neoplasm Diseases 0.000 description 2
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
201000000459 head and neck squamous cell carcinoma Diseases 0.000 description 2
210000003958 hematopoietic stem cell Anatomy 0.000 description 2
208000002672 hepatitis B Diseases 0.000 description 2
208000029824 high grade glioma Diseases 0.000 description 2
102000049109 human HAVCR2 Human genes 0.000 description 2
102000057058 human VSIR Human genes 0.000 description 2
210000004408 hybridoma Anatomy 0.000 description 2
230000002267 hypothalamic effect Effects 0.000 description 2
210000003016 hypothalamus Anatomy 0.000 description 2
229940126546 immune checkpoint molecule Drugs 0.000 description 2
230000002163 immunogen Effects 0.000 description 2
230000003259 immunoinhibitory effect Effects 0.000 description 2
210000000428 immunological synapse Anatomy 0.000 description 2
230000008595 infiltration Effects 0.000 description 2
238000001764 infiltration Methods 0.000 description 2
108091008042 inhibitory receptors Proteins 0.000 description 2
238000002347 injection Methods 0.000 description 2
239000007924 injection Substances 0.000 description 2
108010044426 integrins Proteins 0.000 description 2
102000006495 integrins Human genes 0.000 description 2
229960003130 interferon gamma Drugs 0.000 description 2
230000000968 intestinal effect Effects 0.000 description 2
238000007912 intraperitoneal administration Methods 0.000 description 2
238000007913 intrathecal administration Methods 0.000 description 2
238000001990 intravenous administration Methods 0.000 description 2
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
229960000310 isoleucine Drugs 0.000 description 2
210000004185 liver Anatomy 0.000 description 2
208000003747 lymphoid leukemia Diseases 0.000 description 2
201000000564 macroglobulinemia Diseases 0.000 description 2
210000002540 macrophage Anatomy 0.000 description 2
201000011614 malignant glioma Diseases 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
108010082117 matrigel Proteins 0.000 description 2
210000003071 memory t lymphocyte Anatomy 0.000 description 2
230000009401 metastasis Effects 0.000 description 2
230000005012 migration Effects 0.000 description 2
238000013508 migration Methods 0.000 description 2
230000004048 modification Effects 0.000 description 2
238000012986 modification Methods 0.000 description 2
229940126619 mouse monoclonal antibody Drugs 0.000 description 2
208000025113 myeloid leukemia Diseases 0.000 description 2
208000037830 nasal cancer Diseases 0.000 description 2
210000005036 nerve Anatomy 0.000 description 2
208000002154 non-small cell lung carcinoma Diseases 0.000 description 2
201000008106 ocular cancer Diseases 0.000 description 2
201000008968 osteosarcoma Diseases 0.000 description 2
210000001672 ovary Anatomy 0.000 description 2
108010044156 peptidyl-prolyl cis-trans isomerase b Proteins 0.000 description 2
102000020233 phosphotransferase Human genes 0.000 description 2
229920000642 polymer Polymers 0.000 description 2
229920002981 polyvinylidene fluoride Polymers 0.000 description 2
230000003449 preventive effect Effects 0.000 description 2
208000016800 primary central nervous system lymphoma Diseases 0.000 description 2
239000000047 product Substances 0.000 description 2
108010043671 prostatic acid phosphatase Proteins 0.000 description 2
125000006239 protecting group Chemical group 0.000 description 2
108700015048 receptor decoy activity proteins Proteins 0.000 description 2
239000012723 sample buffer Substances 0.000 description 2
208000037968 sinus cancer Diseases 0.000 description 2
210000004872 soft tissue Anatomy 0.000 description 2
230000004936 stimulating effect Effects 0.000 description 2
238000006467 substitution reaction Methods 0.000 description 2
230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 2
208000024891 symptom Diseases 0.000 description 2
230000001225 therapeutic effect Effects 0.000 description 2
102000052185 transforming growth factor beta receptor activity proteins Human genes 0.000 description 2
108700015056 transforming growth factor beta receptor activity proteins Proteins 0.000 description 2
108091007466 transmembrane glycoproteins Proteins 0.000 description 2
201000008827 tuberculosis Diseases 0.000 description 2
208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 2
125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 2
238000012762 unpaired Student’s t-test Methods 0.000 description 2
210000001635 urinary tract Anatomy 0.000 description 2
230000003442 weekly effect Effects 0.000 description 2
238000001262 western blot Methods 0.000 description 2
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
MHJJUOJOAJLYBS-ZBRNBAAYSA-N (2s)-2-aminopropanoic acid;(2s)-pyrrolidine-2-carboxylic acid Chemical compound C[C@H](N)C(O)=O.OC(=O)[C@@H]1CCCN1 MHJJUOJOAJLYBS-ZBRNBAAYSA-N 0.000 description 1
MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
NMWKYTGJWUAZPZ-WWHBDHEGSA-N (4S)-4-[[(4R,7S,10S,16S,19S,25S,28S,31R)-31-[[(2S)-2-[[(1R,6R,9S,12S,18S,21S,24S,27S,30S,33S,36S,39S,42R,47R,53S,56S,59S,62S,65S,68S,71S,76S,79S,85S)-47-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-3-methylbutanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-3-phenylpropanoyl]amino]-4-oxobutanoyl]amino]-3-carboxypropanoyl]amino]-18-(4-aminobutyl)-27,68-bis(3-amino-3-oxopropyl)-36,71,76-tribenzyl-39-(3-carbamimidamidopropyl)-24-(2-carboxyethyl)-21,56-bis(carboxymethyl)-65,85-bis[(1R)-1-hydroxyethyl]-59-(hydroxymethyl)-62,79-bis(1H-imidazol-4-ylmethyl)-9-methyl-33-(2-methylpropyl)-8,11,17,20,23,26,29,32,35,38,41,48,54,57,60,63,66,69,72,74,77,80,83,86-tetracosaoxo-30-propan-2-yl-3,4,44,45-tetrathia-7,10,16,19,22,25,28,31,34,37,40,49,55,58,61,64,67,70,73,75,78,81,84,87-tetracosazatetracyclo[40.31.14.012,16.049,53]heptaoctacontane-6-carbonyl]amino]-3-methylbutanoyl]amino]-7-(3-carbamimidamidopropyl)-25-(hydroxymethyl)-19-[(4-hydroxyphenyl)methyl]-28-(1H-imidazol-4-ylmethyl)-10-methyl-6,9,12,15,18,21,24,27,30-nonaoxo-16-propan-2-yl-1,2-dithia-5,8,11,14,17,20,23,26,29-nonazacyclodotriacontane-4-carbonyl]amino]-5-[[(2S)-1-[[(2S)-1-[[(2S)-3-carboxy-1-[[(2S)-1-[[(2S)-1-[[(1S)-1-carboxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid Chemical compound CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc4c[nH]cn4)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc4c[nH]cn4)NC(=O)[C@H](Cc4ccccc4)NC3=O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N3CCC[C@H]3C(=O)N[C@@H](C)C(=O)N2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1)C(=O)N[C@@H](C)C(O)=O NMWKYTGJWUAZPZ-WWHBDHEGSA-N 0.000 description 1
SSOORFWOBGFTHL-OTEJMHTDSA-N (4S)-5-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[(2S)-2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-5-carbamimidamido-1-[[(2S)-5-carbamimidamido-1-[[(1S)-4-carbamimidamido-1-carboxybutyl]amino]-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-oxoethyl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-[[(2S)-2-[[(2S)-2-[[(2S)-2,6-diaminohexanoyl]amino]-3-methylbutanoyl]amino]propanoyl]amino]-5-oxopentanoic acid Chemical compound CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O SSOORFWOBGFTHL-OTEJMHTDSA-N 0.000 description 1
CDKIEBFIMCSCBB-UHFFFAOYSA-N 1-(6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)-3-(1-methyl-2-phenylpyrrolo[2,3-b]pyridin-3-yl)prop-2-en-1-one;hydrochloride Chemical compound Cl.C1C=2C=C(OC)C(OC)=CC=2CCN1C(=O)C=CC(C1=CC=CN=C1N1C)=C1C1=CC=CC=C1 CDKIEBFIMCSCBB-UHFFFAOYSA-N 0.000 description 1
102000010400 1-phosphatidylinositol-3-kinase activity proteins Human genes 0.000 description 1
LKKMLIBUAXYLOY-UHFFFAOYSA-N 3-Amino-1-methyl-5H-pyrido[4,3-b]indole Chemical compound N1C2=CC=CC=C2C2=C1C=C(N)N=C2C LKKMLIBUAXYLOY-UHFFFAOYSA-N 0.000 description 1
WEVYNIUIFUYDGI-UHFFFAOYSA-N 3-[6-[4-(trifluoromethoxy)anilino]-4-pyrimidinyl]benzamide Chemical compound NC(=O)C1=CC=CC(C=2N=CN=C(NC=3C=CC(OC(F)(F)F)=CC=3)C=2)=C1 WEVYNIUIFUYDGI-UHFFFAOYSA-N 0.000 description 1
208000002008 AIDS-Related Lymphoma Diseases 0.000 description 1
RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical class CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 1
208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 1
208000031261 Acute myeloid leukaemia Diseases 0.000 description 1
102100021305 Acyl-CoA:lysophosphatidylglycerol acyltransferase 1 Human genes 0.000 description 1
102000007471 Adenosine A2A receptor Human genes 0.000 description 1
108010085277 Adenosine A2A receptor Proteins 0.000 description 1
102100032959 Alpha-actinin-4 Human genes 0.000 description 1
101710115256 Alpha-actinin-4 Proteins 0.000 description 1
102100023635 Alpha-fetoprotein Human genes 0.000 description 1
206010061424 Anal cancer Diseases 0.000 description 1
102000009088 Angiopoietin-1 Human genes 0.000 description 1
108010048154 Angiopoietin-1 Proteins 0.000 description 1
102100034608 Angiopoietin-2 Human genes 0.000 description 1
108010048036 Angiopoietin-2 Proteins 0.000 description 1
208000007860 Anus Neoplasms Diseases 0.000 description 1
241000271566 Aves Species 0.000 description 1
102100035526 B melanoma antigen 1 Human genes 0.000 description 1
208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 1
102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 1
102100022005 B-lymphocyte antigen CD20 Human genes 0.000 description 1
208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 description 1
229940125565 BMS-986016 Drugs 0.000 description 1
229940122494 BTLA agonist Drugs 0.000 description 1
102000015735 Beta-catenin Human genes 0.000 description 1
108060000903 Beta-catenin Proteins 0.000 description 1
208000008720 Bone Marrow Neoplasms Diseases 0.000 description 1
206010005949 Bone cancer Diseases 0.000 description 1
208000018084 Bone neoplasm Diseases 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
208000006274 Brain Stem Neoplasms Diseases 0.000 description 1
102100029894 Bromodomain testis-specific protein Human genes 0.000 description 1
OBMZMSLWNNWEJA-XNCRXQDQSA-N C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 Chemical compound C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 OBMZMSLWNNWEJA-XNCRXQDQSA-N 0.000 description 1
102100024217 CAMPATH-1 antigen Human genes 0.000 description 1
108010065524 CD52 Antigen Proteins 0.000 description 1
102100025221 CD70 antigen Human genes 0.000 description 1
241000282832 Camelidae Species 0.000 description 1
102100039510 Cancer/testis antigen 2 Human genes 0.000 description 1
241000282472 Canis lupus familiaris Species 0.000 description 1
235000002566 Capsicum Nutrition 0.000 description 1
240000008574 Capsicum frutescens Species 0.000 description 1
102100028914 Catenin beta-1 Human genes 0.000 description 1
108010072135 Cell Adhesion Molecule-1 Proteins 0.000 description 1
102100024649 Cell adhesion molecule 1 Human genes 0.000 description 1
206010057250 Cell-mediated cytotoxicity Diseases 0.000 description 1
231100000023 Cell-mediated cytotoxicity Toxicity 0.000 description 1
102100023441 Centromere protein J Human genes 0.000 description 1
101710181340 Chaperone protein DnaK2 Proteins 0.000 description 1
102000019034 Chemokines Human genes 0.000 description 1
108010012236 Chemokines Proteins 0.000 description 1
208000010833 Chronic myeloid leukaemia Diseases 0.000 description 1
235000008733 Citrus aurantifolia Nutrition 0.000 description 1
206010073140 Clear cell sarcoma of soft tissue Diseases 0.000 description 1
102000011591 Cleavage And Polyadenylation Specificity Factor Human genes 0.000 description 1
108010076130 Cleavage And Polyadenylation Specificity Factor Proteins 0.000 description 1
102100032368 Coiled-coil domain-containing protein 110 Human genes 0.000 description 1
208000001333 Colorectal Neoplasms Diseases 0.000 description 1
108010043471 Core Binding Factor Alpha 2 Subunit Proteins 0.000 description 1
108010009392 Cyclin-Dependent Kinase Inhibitor p16 Proteins 0.000 description 1
102100024458 Cyclin-dependent kinase inhibitor 2A Human genes 0.000 description 1
102100027350 Cysteine-rich secretory protein 2 Human genes 0.000 description 1
SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
102000009058 Death Domain Receptors Human genes 0.000 description 1
108010049207 Death Domain Receptors Proteins 0.000 description 1
102100037981 Dickkopf-like protein 1 Human genes 0.000 description 1
101710125833 Dickkopf-like protein 1 Proteins 0.000 description 1
108050002772 E3 ubiquitin-protein ligase Mdm2 Proteins 0.000 description 1
102000012199 E3 ubiquitin-protein ligase Mdm2 Human genes 0.000 description 1
102100026245 E3 ubiquitin-protein ligase RNF43 Human genes 0.000 description 1
102100037238 E3 ubiquitin-protein ligase UBR4 Human genes 0.000 description 1
241000283074 Equus asinus Species 0.000 description 1
241000588724 Escherichia coli Species 0.000 description 1
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
108010014172 Factor V Proteins 0.000 description 1
108010087819 Fc receptors Proteins 0.000 description 1
102000009109 Fc receptors Human genes 0.000 description 1
108091006020 Fc-tagged proteins Proteins 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
108010069446 Fertilins Proteins 0.000 description 1
102000001133 Fertilins Human genes 0.000 description 1
108090000380 Fibroblast growth factor 5 Proteins 0.000 description 1
102100028073 Fibroblast growth factor 5 Human genes 0.000 description 1
102100020714 Fragile X mental retardation 1 neighbor protein Human genes 0.000 description 1
PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
108010019236 Fucosyltransferases Proteins 0.000 description 1
102000006471 Fucosyltransferases Human genes 0.000 description 1
102100039717 G antigen 1 Human genes 0.000 description 1
102100029974 GTPase HRas Human genes 0.000 description 1
208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
208000031448 Genomic Instability Diseases 0.000 description 1
208000021309 Germ cell tumor Diseases 0.000 description 1
102000006395 Globulins Human genes 0.000 description 1
108010044091 Globulins Proteins 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
102000003886 Glycoproteins Human genes 0.000 description 1
108090000288 Glycoproteins Proteins 0.000 description 1
102000006771 Gonadotropins Human genes 0.000 description 1
108010086677 Gonadotropins Proteins 0.000 description 1
206010018612 Gonorrhoea Diseases 0.000 description 1
241000282575 Gorilla Species 0.000 description 1
108091008603 HGF receptors Proteins 0.000 description 1
102000027430 HGF receptors Human genes 0.000 description 1
102100028972 HLA class I histocompatibility antigen, A alpha chain Human genes 0.000 description 1
108010075704 HLA-A Antigens Proteins 0.000 description 1
102000025850 HLA-A2 Antigen Human genes 0.000 description 1
101150046249 Havcr2 gene Proteins 0.000 description 1
101710178419 Heat shock protein 70 2 Proteins 0.000 description 1
102000002812 Heat-Shock Proteins Human genes 0.000 description 1
108010004889 Heat-Shock Proteins Proteins 0.000 description 1
102100035108 High affinity nerve growth factor receptor Human genes 0.000 description 1
241001272567 Hominoidea Species 0.000 description 1
101001042227 Homo sapiens Acyl-CoA:lysophosphatidylglycerol acyltransferase 1 Proteins 0.000 description 1
101000951392 Homo sapiens Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A Proteins 0.000 description 1
101000874316 Homo sapiens B melanoma antigen 1 Proteins 0.000 description 1
101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 1
101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 description 1
101000794028 Homo sapiens Bromodomain testis-specific protein Proteins 0.000 description 1
101000934356 Homo sapiens CD70 antigen Proteins 0.000 description 1
101000889345 Homo sapiens Cancer/testis antigen 2 Proteins 0.000 description 1
101000916173 Homo sapiens Catenin beta-1 Proteins 0.000 description 1
101000721661 Homo sapiens Cellular tumor antigen p53 Proteins 0.000 description 1
101000907924 Homo sapiens Centromere protein J Proteins 0.000 description 1
101000868824 Homo sapiens Coiled-coil domain-containing protein 110 Proteins 0.000 description 1
101000726255 Homo sapiens Cysteine-rich secretory protein 2 Proteins 0.000 description 1
101000692702 Homo sapiens E3 ubiquitin-protein ligase RNF43 Proteins 0.000 description 1
101000807547 Homo sapiens E3 ubiquitin-protein ligase UBR4 Proteins 0.000 description 1
101000932499 Homo sapiens Fragile X mental retardation 1 neighbor protein Proteins 0.000 description 1
101000886137 Homo sapiens G antigen 1 Proteins 0.000 description 1
101000584633 Homo sapiens GTPase HRas Proteins 0.000 description 1
101000596894 Homo sapiens High affinity nerve growth factor receptor Proteins 0.000 description 1
101001019455 Homo sapiens ICOS ligand Proteins 0.000 description 1
101000614481 Homo sapiens Kidney-associated antigen 1 Proteins 0.000 description 1
101000971521 Homo sapiens Kinetochore scaffold 1 Proteins 0.000 description 1
101001130171 Homo sapiens L-lactate dehydrogenase C chain Proteins 0.000 description 1
101001051093 Homo sapiens Low-density lipoprotein receptor Proteins 0.000 description 1
101001014223 Homo sapiens MAPK/MAK/MRK overlapping kinase Proteins 0.000 description 1
101001028659 Homo sapiens MORC family CW-type zinc finger protein 1 Proteins 0.000 description 1
101000825217 Homo sapiens Meiotic recombination protein SPO11 Proteins 0.000 description 1
101000620359 Homo sapiens Melanocyte protein PMEL Proteins 0.000 description 1
101000578784 Homo sapiens Melanoma antigen recognized by T-cells 1 Proteins 0.000 description 1
101001036675 Homo sapiens Melanoma-associated antigen B6 Proteins 0.000 description 1
101001036406 Homo sapiens Melanoma-associated antigen C1 Proteins 0.000 description 1
101001057156 Homo sapiens Melanoma-associated antigen C2 Proteins 0.000 description 1
101000628547 Homo sapiens Metalloreductase STEAP1 Proteins 0.000 description 1
101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 description 1
101000597425 Homo sapiens Nuclear RNA export factor 2 Proteins 0.000 description 1
101000588345 Homo sapiens Nuclear transcription factor Y subunit gamma Proteins 0.000 description 1
101001114051 Homo sapiens P antigen family member 5 Proteins 0.000 description 1
101000619805 Homo sapiens Peroxiredoxin-5, mitochondrial Proteins 0.000 description 1
101000605639 Homo sapiens Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Proteins 0.000 description 1
101000610208 Homo sapiens Poly(A) polymerase gamma Proteins 0.000 description 1
101000874141 Homo sapiens Probable ATP-dependent RNA helicase DDX43 Proteins 0.000 description 1
101001136981 Homo sapiens Proteasome subunit beta type-9 Proteins 0.000 description 1
101000842302 Homo sapiens Protein-cysteine N-palmitoyltransferase HHAT Proteins 0.000 description 1
101000745415 Homo sapiens Putative chondrosarcoma-associated gene 1 protein Proteins 0.000 description 1
101000679365 Homo sapiens Putative tyrosine-protein phosphatase TPTE Proteins 0.000 description 1
101000591201 Homo sapiens Receptor-type tyrosine-protein phosphatase kappa Proteins 0.000 description 1
101001073409 Homo sapiens Retrotransposon-derived protein PEG10 Proteins 0.000 description 1
101000693082 Homo sapiens Serine/threonine-protein kinase 11-interacting protein Proteins 0.000 description 1
101000665150 Homo sapiens Small nuclear ribonucleoprotein Sm D1 Proteins 0.000 description 1
101000665250 Homo sapiens Small nuclear ribonucleoprotein Sm D2 Proteins 0.000 description 1
101000825253 Homo sapiens Sperm protein associated with the nucleus on the X chromosome A Proteins 0.000 description 1
101000643620 Homo sapiens Synaptonemal complex protein 1 Proteins 0.000 description 1
101000831007 Homo sapiens T-cell immunoreceptor with Ig and ITIM domains Proteins 0.000 description 1
101000596845 Homo sapiens Testis-expressed protein 15 Proteins 0.000 description 1
101000666379 Homo sapiens Transcription factor Dp family member 3 Proteins 0.000 description 1
101000664703 Homo sapiens Transcription factor SOX-10 Proteins 0.000 description 1
101000904724 Homo sapiens Transmembrane glycoprotein NMB Proteins 0.000 description 1
101000889756 Homo sapiens Tudor domain-containing protein 1 Proteins 0.000 description 1
101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 description 1
101100049559 Homo sapiens VSIG8 gene Proteins 0.000 description 1
206010021042 Hypopharyngeal cancer Diseases 0.000 description 1
206010056305 Hypopharyngeal neoplasm Diseases 0.000 description 1
102100034980 ICOS ligand Human genes 0.000 description 1
XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
229940076838 Immune checkpoint inhibitor Drugs 0.000 description 1
108091008029 Immune checkpoint ligands Proteins 0.000 description 1
102000037977 Immune checkpoint ligands Human genes 0.000 description 1
102000037978 Immune checkpoint receptors Human genes 0.000 description 1
108091008028 Immune checkpoint receptors Proteins 0.000 description 1
108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
108010043496 Immunoglobulin Idiotypes Proteins 0.000 description 1
108010067060 Immunoglobulin Variable Region Proteins 0.000 description 1
102000017727 Immunoglobulin Variable Region Human genes 0.000 description 1
102000016844 Immunoglobulin-like domains Human genes 0.000 description 1
108050006430 Immunoglobulin-like domains Proteins 0.000 description 1
206010061218 Inflammation Diseases 0.000 description 1
102000007482 Interleukin-13 Receptor alpha2 Subunit Human genes 0.000 description 1
108010085418 Interleukin-13 Receptor alpha2 Subunit Proteins 0.000 description 1
108010002350 Interleukin-2 Proteins 0.000 description 1
102000000588 Interleukin-2 Human genes 0.000 description 1
108010038453 Interleukin-2 Receptors Proteins 0.000 description 1
102000010789 Interleukin-2 Receptors Human genes 0.000 description 1
102000004388 Interleukin-4 Human genes 0.000 description 1
108090000978 Interleukin-4 Proteins 0.000 description 1
108010038486 Interleukin-4 Receptors Proteins 0.000 description 1
102000010787 Interleukin-4 Receptors Human genes 0.000 description 1
102000010781 Interleukin-6 Receptors Human genes 0.000 description 1
108010038501 Interleukin-6 Receptors Proteins 0.000 description 1
208000005016 Intestinal Neoplasms Diseases 0.000 description 1
206010061252 Intraocular melanoma Diseases 0.000 description 1
102100040442 Kidney-associated antigen 1 Human genes 0.000 description 1
102100021464 Kinetochore scaffold 1 Human genes 0.000 description 1
241000588747 Klebsiella pneumoniae Species 0.000 description 1
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
102100031413 L-dopachrome tautomerase Human genes 0.000 description 1
101710093778 L-dopachrome tautomerase Proteins 0.000 description 1
SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
102100031357 L-lactate dehydrogenase C chain Human genes 0.000 description 1
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
108091008555 LTK receptors Proteins 0.000 description 1
102100025640 Lactase-like protein Human genes 0.000 description 1
101150030213 Lag3 gene Proteins 0.000 description 1
102100028047 Large proline-rich protein BAG6 Human genes 0.000 description 1
101710196180 Large proline-rich protein BAG6 Proteins 0.000 description 1
208000032420 Latent Infection Diseases 0.000 description 1
206010024229 Leprosy Diseases 0.000 description 1
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
102100024640 Low-density lipoprotein receptor Human genes 0.000 description 1
208000007433 Lymphatic Metastasis Diseases 0.000 description 1
208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 description 1
208000028018 Lymphocytic leukaemia Diseases 0.000 description 1
206010025312 Lymphoma AIDS related Diseases 0.000 description 1
102100031520 MAPK/MAK/MRK overlapping kinase Human genes 0.000 description 1
102100037200 MORC family CW-type zinc finger protein 1 Human genes 0.000 description 1
108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
102100028123 Macrophage colony-stimulating factor 1 Human genes 0.000 description 1
208000004059 Male Breast Neoplasms Diseases 0.000 description 1
208000006644 Malignant Fibrous Histiocytoma Diseases 0.000 description 1
206010025557 Malignant fibrous histiocytoma of bone Diseases 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
102100022253 Meiotic recombination protein SPO11 Human genes 0.000 description 1
102100039483 Melanoma-associated antigen B6 Human genes 0.000 description 1
102100039447 Melanoma-associated antigen C1 Human genes 0.000 description 1
102100027252 Melanoma-associated antigen C2 Human genes 0.000 description 1
208000002030 Merkel cell carcinoma Diseases 0.000 description 1
102100026712 Metalloreductase STEAP1 Human genes 0.000 description 1
235000019957 Mimix Nutrition 0.000 description 1
102100025751 Mothers against decapentaplegic homolog 2 Human genes 0.000 description 1
101710143123 Mothers against decapentaplegic homolog 2 Proteins 0.000 description 1
102100025748 Mothers against decapentaplegic homolog 3 Human genes 0.000 description 1
101710143111 Mothers against decapentaplegic homolog 3 Proteins 0.000 description 1
102100025725 Mothers against decapentaplegic homolog 4 Human genes 0.000 description 1
101710143112 Mothers against decapentaplegic homolog 4 Proteins 0.000 description 1
108091008553 MuSK receptors Proteins 0.000 description 1
108010063954 Mucins Proteins 0.000 description 1
101100490443 Mus musculus Acvr1 gene Proteins 0.000 description 1
101100407308 Mus musculus Pdcd1lg2 gene Proteins 0.000 description 1
101000597780 Mus musculus Tumor necrosis factor ligand superfamily member 18 Proteins 0.000 description 1
101100023550 Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97) cmaD gene Proteins 0.000 description 1
201000003793 Myelodysplastic syndrome Diseases 0.000 description 1
208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 description 1
208000033776 Myeloid Acute Leukemia Diseases 0.000 description 1
102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 description 1
208000014767 Myeloproliferative disease Diseases 0.000 description 1
201000007224 Myeloproliferative neoplasm Diseases 0.000 description 1
102000003505 Myosin Human genes 0.000 description 1
108060008487 Myosin Chemical class 0.000 description 1
102100022913 NAD-dependent protein deacetylase sirtuin-2 Human genes 0.000 description 1
101150065403 NECTIN2 gene Proteins 0.000 description 1
108700031757 NKTR-214 Proteins 0.000 description 1
208000034176 Neoplasms, Germ Cell and Embryonal Diseases 0.000 description 1
206010029260 Neuroblastoma Diseases 0.000 description 1
206010029266 Neuroendocrine carcinoma of the skin Diseases 0.000 description 1
102100035403 Nuclear RNA export factor 2 Human genes 0.000 description 1
102100031719 Nuclear transcription factor Y subunit gamma Human genes 0.000 description 1
102000004473 OX40 Ligand Human genes 0.000 description 1
108010042215 OX40 Ligand Proteins 0.000 description 1
208000008589 Obesity Diseases 0.000 description 1
206010031096 Oropharyngeal cancer Diseases 0.000 description 1
206010057444 Oropharyngeal neoplasm Diseases 0.000 description 1
102100023238 P antigen family member 5 Human genes 0.000 description 1
239000012269 PD-1/PD-L1 inhibitor Substances 0.000 description 1
239000012271 PD-L1 inhibitor Substances 0.000 description 1
108091007960 PI3Ks Proteins 0.000 description 1
108010011536 PTEN Phosphohydrolase Proteins 0.000 description 1
102000014160 PTEN Phosphohydrolase Human genes 0.000 description 1
102100034640 PWWP domain-containing DNA repair factor 3A Human genes 0.000 description 1
108050007154 PWWP domain-containing DNA repair factor 3A Proteins 0.000 description 1
241000282579 Pan Species 0.000 description 1
208000000821 Parathyroid Neoplasms Diseases 0.000 description 1
208000002471 Penile Neoplasms Diseases 0.000 description 1
206010034299 Penile cancer Diseases 0.000 description 1
101710176384 Peptide 1 Proteins 0.000 description 1
102100022078 Peroxiredoxin-5, mitochondrial Human genes 0.000 description 1
208000037581 Persistent Infection Diseases 0.000 description 1
206010057249 Phagocytosis Diseases 0.000 description 1
102100038332 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Human genes 0.000 description 1
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
235000011613 Pinus brutia Nutrition 0.000 description 1
241000018646 Pinus brutia Species 0.000 description 1
208000007913 Pituitary Neoplasms Diseases 0.000 description 1
206010035664 Pneumonia Diseases 0.000 description 1
102100040153 Poly(A) polymerase gamma Human genes 0.000 description 1
241000282405 Pongo abelii Species 0.000 description 1
102100025067 Potassium voltage-gated channel subfamily H member 4 Human genes 0.000 description 1
101710163352 Potassium voltage-gated channel subfamily H member 4 Proteins 0.000 description 1
102100035724 Probable ATP-dependent RNA helicase DDX43 Human genes 0.000 description 1
101710089372 Programmed cell death protein 1 Proteins 0.000 description 1
108091007744 Programmed cell death receptors Proteins 0.000 description 1
102100035764 Proteasome subunit beta type-9 Human genes 0.000 description 1
108010029485 Protein Isoforms Proteins 0.000 description 1
102000001708 Protein Isoforms Human genes 0.000 description 1
102000018471 Proto-Oncogene Proteins B-raf Human genes 0.000 description 1
108010091528 Proto-Oncogene Proteins B-raf Proteins 0.000 description 1
201000008183 Pulmonary blastoma Diseases 0.000 description 1
102100039359 Putative chondrosarcoma-associated gene 1 protein Human genes 0.000 description 1
102100022578 Putative tyrosine-protein phosphatase TPTE Human genes 0.000 description 1
108091008551 RET receptors Proteins 0.000 description 1
108091008552 RYK receptors Proteins 0.000 description 1
102000010498 Receptor Activator of Nuclear Factor-kappa B Human genes 0.000 description 1
108010038036 Receptor Activator of Nuclear Factor-kappa B Proteins 0.000 description 1
102000005435 Receptor Tyrosine Kinase-like Orphan Receptors Human genes 0.000 description 1
108010006700 Receptor Tyrosine Kinase-like Orphan Receptors Proteins 0.000 description 1
102100034089 Receptor-type tyrosine-protein phosphatase kappa Human genes 0.000 description 1
206010070308 Refractory cancer Diseases 0.000 description 1
208000006265 Renal cell carcinoma Diseases 0.000 description 1
102100035844 Retrotransposon-derived protein PEG10 Human genes 0.000 description 1
241000283984 Rodentia Species 0.000 description 1
102000014400 SH2 domains Human genes 0.000 description 1
108050003452 SH2 domains Proteins 0.000 description 1
108091058557 SILV Proteins 0.000 description 1
108700019345 SYT-SSX fusion Proteins 0.000 description 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
101710173694 Short transient receptor potential channel 2 Proteins 0.000 description 1
241000700584 Simplexvirus Species 0.000 description 1
108010041216 Sirtuin 2 Proteins 0.000 description 1
206010041067 Small cell lung cancer Diseases 0.000 description 1
102100038685 Small nuclear ribonucleoprotein Sm D2 Human genes 0.000 description 1
102100022327 Sperm protein associated with the nucleus on the X chromosome A Human genes 0.000 description 1
208000005718 Stomach Neoplasms Diseases 0.000 description 1
241000282887 Suidae Species 0.000 description 1
102100036234 Synaptonemal complex protein 1 Human genes 0.000 description 1
230000017274 T cell anergy Effects 0.000 description 1
230000033540 T cell apoptotic process Effects 0.000 description 1
208000031673 T-Cell Cutaneous Lymphoma Diseases 0.000 description 1
102100024834 T-cell immunoreceptor with Ig and ITIM domains Human genes 0.000 description 1
206010042971 T-cell lymphoma Diseases 0.000 description 1
208000027585 T-cell non-Hodgkin lymphoma Diseases 0.000 description 1
101150000629 TGFB1 gene Proteins 0.000 description 1
102000005450 TIE receptors Human genes 0.000 description 1
108010006830 TIE receptors Proteins 0.000 description 1
102100035116 Testis-expressed protein 15 Human genes 0.000 description 1
235000011941 Tilia x europaea Nutrition 0.000 description 1
102100038129 Transcription factor Dp family member 3 Human genes 0.000 description 1
102100038808 Transcription factor SOX-10 Human genes 0.000 description 1
108700015934 Triose-phosphate isomerases Proteins 0.000 description 1
102100033598 Triosephosphate isomerase Human genes 0.000 description 1
102100040192 Tudor domain-containing protein 1 Human genes 0.000 description 1
108010078814 Tumor Suppressor Protein p53 Proteins 0.000 description 1
102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 description 1
108091005906 Type I transmembrane proteins Proteins 0.000 description 1
102100037236 Tyrosine-protein kinase receptor UFO Human genes 0.000 description 1
208000015778 Undifferentiated pleomorphic sarcoma Diseases 0.000 description 1
201000005969 Uveal melanoma Diseases 0.000 description 1
241000251539 Vertebrata <Metazoa> Species 0.000 description 1
208000036142 Viral infection Diseases 0.000 description 1
208000008383 Wilms tumor Diseases 0.000 description 1
230000001594 aberrant effect Effects 0.000 description 1
230000005856 abnormality Effects 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
239000002253 acid Substances 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
230000009471 action Effects 0.000 description 1
230000033289 adaptive immune response Effects 0.000 description 1
210000005006 adaptive immune system Anatomy 0.000 description 1
108010071391 adenocarcinoma antigen recognized by T cells-4 Proteins 0.000 description 1
229960000548 alemtuzumab Drugs 0.000 description 1
108010034034 alpha-1,6-mannosylglycoprotein beta 1,6-N-acetylglucosaminyltransferase Proteins 0.000 description 1
102000013529 alpha-Fetoproteins Human genes 0.000 description 1
108010026331 alpha-Fetoproteins Proteins 0.000 description 1
230000003321 amplification Effects 0.000 description 1
238000005349 anion exchange Methods 0.000 description 1
230000003042 antagnostic effect Effects 0.000 description 1
230000005875 antibody response Effects 0.000 description 1
230000000890 antigenic effect Effects 0.000 description 1
239000002246 antineoplastic agent Substances 0.000 description 1
201000011165 anus cancer Diseases 0.000 description 1
230000001640 apoptogenic effect Effects 0.000 description 1
229960004669 basiliximab Drugs 0.000 description 1
229940121413 bempegaldesleukin Drugs 0.000 description 1
WQZGKKKJIJFFOK-FPRJBGLDSA-N beta-D-galactose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-FPRJBGLDSA-N 0.000 description 1
230000001588 bifunctional effect Effects 0.000 description 1
208000026900 bile duct neoplasm Diseases 0.000 description 1
201000009036 biliary tract cancer Diseases 0.000 description 1
208000020790 biliary tract neoplasm Diseases 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
230000029918 bioluminescence Effects 0.000 description 1
238000005415 bioluminescence Methods 0.000 description 1
210000004204 blood vessel Anatomy 0.000 description 1
210000000988 bone and bone Anatomy 0.000 description 1
201000006491 bone marrow cancer Diseases 0.000 description 1
201000008873 bone osteosarcoma Diseases 0.000 description 1
210000000133 brain stem Anatomy 0.000 description 1
210000000481 breast Anatomy 0.000 description 1
229960000455 brentuximab vedotin Drugs 0.000 description 1
201000002143 bronchus adenoma Diseases 0.000 description 1
239000006227 byproduct Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000011575 calcium Substances 0.000 description 1
238000002619 cancer immunotherapy Methods 0.000 description 1
239000001390 capsicum minimum Substances 0.000 description 1
210000000234 capsid Anatomy 0.000 description 1
230000001364 causal effect Effects 0.000 description 1
210000004970 cd4 cell Anatomy 0.000 description 1
230000020411 cell activation Effects 0.000 description 1
230000030833 cell death Effects 0.000 description 1
230000010261 cell growth Effects 0.000 description 1
230000005890 cell-mediated cytotoxicity Effects 0.000 description 1
230000005754 cellular signaling Effects 0.000 description 1
210000003850 cellular structure Anatomy 0.000 description 1
230000002490 cerebral effect Effects 0.000 description 1
210000004720 cerebrum Anatomy 0.000 description 1
238000001311 chemical methods and process Methods 0.000 description 1
208000006990 cholangiocarcinoma Diseases 0.000 description 1
210000004252 chorionic villi Anatomy 0.000 description 1
208000032852 chronic lymphocytic leukemia Diseases 0.000 description 1
201000000292 clear cell sarcoma Diseases 0.000 description 1
230000004186 co-expression Effects 0.000 description 1
230000000112 colonic effect Effects 0.000 description 1
238000011220 combination immunotherapy Methods 0.000 description 1
230000009827 complement-dependent cellular cytotoxicity Effects 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
239000000470 constituent Substances 0.000 description 1
238000010276 construction Methods 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
238000004132 cross linking Methods 0.000 description 1
201000007241 cutaneous T cell lymphoma Diseases 0.000 description 1
208000017763 cutaneous neuroendocrine carcinoma Diseases 0.000 description 1
229940127089 cytotoxic agent Drugs 0.000 description 1
229960002204 daratumumab Drugs 0.000 description 1
230000007547 defect Effects 0.000 description 1
229960001251 denosumab Drugs 0.000 description 1
230000001627 detrimental effect Effects 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
230000003467 diminishing effect Effects 0.000 description 1
208000037771 disease arising from reactivation of latent virus Diseases 0.000 description 1
238000010494 dissociation reaction Methods 0.000 description 1
230000005593 dissociations Effects 0.000 description 1
150000002019 disulfides Chemical class 0.000 description 1
235000013399 edible fruits Nutrition 0.000 description 1
229960004137 elotuzumab Drugs 0.000 description 1
239000002158 endotoxin Substances 0.000 description 1
239000003344 environmental pollutant Substances 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
210000001723 extracellular space Anatomy 0.000 description 1
201000008819 extrahepatic bile duct carcinoma Diseases 0.000 description 1
230000008713 feedback mechanism Effects 0.000 description 1
239000000835 fiber Substances 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
238000000684 flow cytometry Methods 0.000 description 1
229960000304 folic acid Drugs 0.000 description 1
239000011724 folic acid Substances 0.000 description 1
238000009472 formulation Methods 0.000 description 1
230000002538 fungal effect Effects 0.000 description 1
206010017758 gastric cancer Diseases 0.000 description 1
229960003297 gemtuzumab ozogamicin Drugs 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
238000010353 genetic engineering Methods 0.000 description 1
210000004392 genitalia Anatomy 0.000 description 1
210000004907 gland Anatomy 0.000 description 1
239000003862 glucocorticoid Substances 0.000 description 1
230000013595 glycosylation Effects 0.000 description 1
238000006206 glycosylation reaction Methods 0.000 description 1
229960001743 golimumab Drugs 0.000 description 1
239000002622 gonadotropin Substances 0.000 description 1
208000001786 gonorrhea Diseases 0.000 description 1
210000003714 granulocyte Anatomy 0.000 description 1
208000035474 group of disease Diseases 0.000 description 1
230000009422 growth inhibiting effect Effects 0.000 description 1
229950010864 guselkumab Drugs 0.000 description 1
210000002768 hair cell Anatomy 0.000 description 1
208000006454 hepatitis Diseases 0.000 description 1
231100000283 hepatitis Toxicity 0.000 description 1
210000003494 hepatocyte Anatomy 0.000 description 1
125000005842 heteroatom Chemical group 0.000 description 1
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
239000000710 homodimer Substances 0.000 description 1
230000003054 hormonal effect Effects 0.000 description 1
201000006866 hypopharynx cancer Diseases 0.000 description 1
230000001900 immune effect Effects 0.000 description 1
230000036737 immune function Effects 0.000 description 1
230000037451 immune surveillance Effects 0.000 description 1
239000012274 immune-checkpoint protein inhibitor Substances 0.000 description 1
230000036039 immunity Effects 0.000 description 1
230000005847 immunogenicity Effects 0.000 description 1
229940072221 immunoglobulins Drugs 0.000 description 1
230000003308 immunostimulating effect Effects 0.000 description 1
229960003444 immunosuppressant agent Drugs 0.000 description 1
230000001861 immunosuppressant effect Effects 0.000 description 1
239000003018 immunosuppressive agent Substances 0.000 description 1
230000006872 improvement Effects 0.000 description 1
230000002779 inactivation Effects 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
238000011534 incubation Methods 0.000 description 1
239000012678 infectious agent Substances 0.000 description 1
230000002458 infectious effect Effects 0.000 description 1
208000027866 inflammatory disease Diseases 0.000 description 1
230000004054 inflammatory process Effects 0.000 description 1
229960000598 infliximab Drugs 0.000 description 1
206010022000 influenza Diseases 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
210000005007 innate immune system Anatomy 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
230000002452 interceptive effect Effects 0.000 description 1
230000004073 interleukin-2 production Effects 0.000 description 1
229940028885 interleukin-4 Drugs 0.000 description 1
201000002313 intestinal cancer Diseases 0.000 description 1
230000005865 ionizing radiation Effects 0.000 description 1
230000001678 irradiating effect Effects 0.000 description 1
210000004153 islets of langerhan Anatomy 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
229950010470 lerdelimumab Drugs 0.000 description 1
239000004571 lime Substances 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
YAFQFNOUYXZVPZ-UHFFFAOYSA-N liproxstatin-1 Chemical compound ClC1=CC=CC(CNC=2C3(CCNCC3)NC3=CC=CC=C3N=2)=C1 YAFQFNOUYXZVPZ-UHFFFAOYSA-N 0.000 description 1
239000007791 liquid phase Substances 0.000 description 1
244000144972 livestock Species 0.000 description 1
230000004807 localization Effects 0.000 description 1
230000000527 lymphocytic effect Effects 0.000 description 1
201000004792 malaria Diseases 0.000 description 1
201000003175 male breast cancer Diseases 0.000 description 1
208000010907 male breast carcinoma Diseases 0.000 description 1
208000026045 malignant tumor of parathyroid gland Diseases 0.000 description 1
230000035800 maturation Effects 0.000 description 1
229950008001 matuzumab Drugs 0.000 description 1
230000010534 mechanism of action Effects 0.000 description 1
108020004999 messenger RNA Proteins 0.000 description 1
229950005555 metelimumab Drugs 0.000 description 1
229930182817 methionine Natural products 0.000 description 1
244000005700 microbiome Species 0.000 description 1
229950003063 mitumomab Drugs 0.000 description 1
101150024128 mmaA1 gene Proteins 0.000 description 1
238000010172 mouse model Methods 0.000 description 1
206010051747 multiple endocrine neoplasia Diseases 0.000 description 1
229960003816 muromonab-cd3 Drugs 0.000 description 1
201000005962 mycosis fungoides Diseases 0.000 description 1
229960005027 natalizumab Drugs 0.000 description 1
230000031942 natural killer cell mediated cytotoxicity Effects 0.000 description 1
238000002663 nebulization Methods 0.000 description 1
208000025189 neoplasm of testis Diseases 0.000 description 1
201000008026 nephroblastoma Diseases 0.000 description 1
210000002569 neuron Anatomy 0.000 description 1
238000003199 nucleic acid amplification method Methods 0.000 description 1
235000020824 obesity Nutrition 0.000 description 1
201000002575 ocular melanoma Diseases 0.000 description 1
229960002450 ofatumumab Drugs 0.000 description 1
230000009437 off-target effect Effects 0.000 description 1
208000022982 optic pathway glioma Diseases 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
210000003463 organelle Anatomy 0.000 description 1
201000006958 oropharynx cancer Diseases 0.000 description 1
229950002610 otelixizumab Drugs 0.000 description 1
230000002611 ovarian Effects 0.000 description 1
208000021284 ovarian germ cell tumor Diseases 0.000 description 1
230000002018 overexpression Effects 0.000 description 1
210000000496 pancreas Anatomy 0.000 description 1
229960005489 paracetamol Drugs 0.000 description 1
230000000803 paradoxical effect Effects 0.000 description 1
230000001575 pathological effect Effects 0.000 description 1
229940121653 pd-1/pd-l1 inhibitor Drugs 0.000 description 1
229940121656 pd-l1 inhibitor Drugs 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
230000008782 phagocytosis Effects 0.000 description 1
239000008194 pharmaceutical composition Substances 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
230000037081 physical activity Effects 0.000 description 1
229920001481 poly(stearyl methacrylate) Polymers 0.000 description 1
238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
230000008488 polyadenylation Effects 0.000 description 1
230000003234 polygenic effect Effects 0.000 description 1
235000017924 poor diet Nutrition 0.000 description 1
239000013641 positive control Substances 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
230000002265 prevention Effects 0.000 description 1
208000025638 primary cutaneous T-cell non-Hodgkin lymphoma Diseases 0.000 description 1
230000008569 process Effects 0.000 description 1
238000004393 prognosis Methods 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
238000011002 quantification Methods 0.000 description 1
102000016914 ras Proteins Human genes 0.000 description 1
230000009257 reactivity Effects 0.000 description 1
238000011084 recovery Methods 0.000 description 1
208000016691 refractory malignant neoplasm Diseases 0.000 description 1
230000014176 regulation of innate immune response Effects 0.000 description 1
230000008844 regulatory mechanism Effects 0.000 description 1
208000015347 renal cell adenocarcinoma Diseases 0.000 description 1
230000008261 resistance mechanism Effects 0.000 description 1
230000004043 responsiveness Effects 0.000 description 1
238000010839 reverse transcription Methods 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
229960004641 rituximab Drugs 0.000 description 1
235000002020 sage Nutrition 0.000 description 1
238000007480 sanger sequencing Methods 0.000 description 1
230000003248 secreting effect Effects 0.000 description 1
230000028327 secretion Effects 0.000 description 1
238000012163 sequencing technique Methods 0.000 description 1
208000012201 sexual and gender identity disease Diseases 0.000 description 1
208000015891 sexual disease Diseases 0.000 description 1
230000001568 sexual effect Effects 0.000 description 1
108091006024 signal transducing proteins Proteins 0.000 description 1
102000034285 signal transducing proteins Human genes 0.000 description 1
238000012174 single-cell RNA sequencing Methods 0.000 description 1
210000003491 skin Anatomy 0.000 description 1
201000008261 skin carcinoma Diseases 0.000 description 1
208000000587 small cell lung carcinoma Diseases 0.000 description 1
230000000391 smoking effect Effects 0.000 description 1
238000005507 spraying Methods 0.000 description 1
108010088201 squamous cell carcinoma-related antigen Proteins 0.000 description 1
201000011549 stomach cancer Diseases 0.000 description 1
230000002459 sustained effect Effects 0.000 description 1
210000000225 synapse Anatomy 0.000 description 1
208000011580 syndromic disease Diseases 0.000 description 1
208000006379 syphilis Diseases 0.000 description 1
210000002435 tendon Anatomy 0.000 description 1
238000012360 testing method Methods 0.000 description 1
238000011200 topical administration Methods 0.000 description 1
230000000699 topical effect Effects 0.000 description 1
238000012546 transfer Methods 0.000 description 1
230000007704 transition Effects 0.000 description 1
102000035160 transmembrane proteins Human genes 0.000 description 1
108091005703 transmembrane proteins Proteins 0.000 description 1
108010075758 trebananib Proteins 0.000 description 1
230000006433 tumor necrosis factor production Effects 0.000 description 1
208000018417 undifferentiated high grade pleomorphic sarcoma of bone Diseases 0.000 description 1
238000011870 unpaired t-test Methods 0.000 description 1
230000003827 upregulation Effects 0.000 description 1
229950005972 urelumab Drugs 0.000 description 1
208000037965 uterine sarcoma Diseases 0.000 description 1
229960005486 vaccine Drugs 0.000 description 1
206010046885 vaginal cancer Diseases 0.000 description 1
208000013139 vaginal neoplasm Diseases 0.000 description 1
239000004474 valine Substances 0.000 description 1
230000009385 viral infection Effects 0.000 description 1

JP2019565233A 2017-05-26 2018-05-25 免疫トレランスを調節するための多機能性の抗体−リガンド・トラップ Pending JP2020521759A (ja)